Insys To Pay $150M To End DOJ Scrutiny Of Opioid-Rx Bribes
Opioid manufacturer Insys Therapeutics Inc. has agreed to pay at least $150 million for the U.S. Department of Justice to drop its criminal investigation and civil claims that the company bribed...To view the full article, register now.
Already a subscriber? Click here to view full article